Rising XDR-Typhoid Fever Cases in Pakistan: Are We Heading Back to the Pre-antibiotic Era?
Front Public Health
.
2022 Jan 17:9:794868.
doi: 10.3389/fpubh.2021.794868.
eCollection 2021.
Authors
Muhammad Hammad Butt
1
,
Aqsa Saleem
2
,
Syed Owais Javed
2
,
Irfan Ullah
3
,
Mujeeb Ur Rehman
4
,
Nayyer Islam
4
,
Muhammad Azam Tahir
5
,
Tangina Malik
6
,
Sara Hafeez
7
,
Shahzadi Misbah
1
Affiliations
1
Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan.
2
Dow University of Health Sciences, Karachi, Pakistan.
3
Kabir Medical College, Gandhara University, Peshawar, Pakistan.
4
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.
5
Khaldunia college of Pharmacy, Lahore, Pakistan.
6
University of the Punjab, Lahore, Pakistan.
7
Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan.
PMID:
35111719
PMCID:
PMC8801676
DOI:
10.3389/fpubh.2021.794868
No abstract available
Keywords:
COVID-19; Pakistan; infectious disease; outbreak; tropical disease.
MeSH terms
Anti-Bacterial Agents / therapeutic use
COVID-19*
Humans
Pakistan
Typhoid Fever* / drug therapy
Substances
Anti-Bacterial Agents